Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Internist (Berl) ; 61(7): 690-698, 2020 Jul.
Article in German | MEDLINE | ID: mdl-32462251

ABSTRACT

Tumor cells always exhibit differences to normal cells. These differences can be recognized by the immune system, enabling the destruction of tumor cells by T cells, as was impressively demonstrated by the success of immune checkpoint inhibition, e.g., in malignant melanoma. Many cancers, however, do not respond to this kind of therapy. In these cases, vaccination against tumor antigens could be very helpful. Nevertheless, all of the efforts made in this respect during the past 30 years have been virtually futile. With current knowledge and technology there is new hope.


Subject(s)
Antigens, Neoplasm/immunology , Cancer Vaccines/therapeutic use , Melanoma/immunology , Neoplasms/immunology , Cancer Vaccines/immunology , Humans , Melanoma/prevention & control , Neoplasms/prevention & control , Neoplasms/therapy , T-Lymphocytes/immunology , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...